COLL
Collegium Pharmaceutical Inc
NASDAQ: COLL · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$33.76
+2.90% today
Updated 2026-04-29
Market cap
$1.09B
P/E ratio
19.51
P/S ratio
1.40x
EPS (TTM)
$1.73
Dividend yield
—
52W range
$27 – $51
Volume
0.6M
Collegium Pharmaceutical Inc (COLL) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$33.76
12-Month target
$41.56
2030 Target
—
Intrinsic (DCF)
$421.65
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.3B | $0.5B | $0.6B | $0.6B | $0.8B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 19.51x (capped 25x) · Margin: 8.05%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.